Profile data is unavailable for this security.
About the company
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The Company’s comprehensive bio simulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. It operates through two segments: software and services. It offers software products for pharmaceutical research, development, and commercialization, including GastroPlus, DDDPlus, MembranePlus, ADMET Predictor, MedChem Designer, DILIsym, NAFLDsym, ILDsym, IPFsym and others. In addition, it also delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development.
- Revenue in USD (TTM)70.01m
- Net income in USD9.95m
- Incorporated1996
- Employees243.00
- LocationSimulations Plus Inc42505 10Th Street WestLANCASTER 93534-7059United StatesUSA
- Phone+1 (661) 723-7723
- Fax+1 (661) 723-5524
- Websitehttps://www.simulations-plus.com/
More ▼
Mergers & acquisitions
| Acquired company | SLP:NSQ since announced | Transaction value |
|---|---|---|
| Pro-ficiency Holdings Inc | -29.53% | 100.00m |
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Semler Scientific Inc | 58.94m | 15.91m | 462.50m | 92.00 | 31.06 | 5.31 | 27.94 | 7.85 | 2.05 | 2.05 | 7.58 | 11.99 | 0.6868 | 17.20 | 9.33 | 640,619.60 | 18.54 | 38.83 | 20.37 | 44.41 | 88.05 | 90.22 | 27.00 | 32.58 | 3.09 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Treace Medical Concepts Inc | 202.86m | -61.52m | 487.79m | 516.00 | -- | 4.65 | -- | 2.40 | -0.9924 | -0.9924 | 3.27 | 1.68 | 0.8951 | 1.08 | 8.25 | 393,141.50 | -27.15 | -- | -32.22 | -- | 80.61 | -- | -30.33 | -- | 2.98 | -- | 0.3366 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Pacific Biosciences of California Inc | 173.15m | -394.24m | 490.55m | 796.00 | -- | 1.09 | -- | 2.83 | -1.46 | -1.46 | 0.64 | 1.65 | 0.1034 | 1.97 | 5.78 | 217,521.40 | -23.55 | -16.19 | -25.40 | -17.81 | 23.81 | 37.35 | -227.69 | -136.21 | 8.64 | -21.87 | 0.6634 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| SI-Bone Inc | 157.04m | -37.40m | 526.74m | 344.00 | -- | 3.18 | -- | 3.35 | -0.9108 | -0.9108 | 3.82 | 3.95 | 0.6859 | 1.46 | 7.00 | 456,497.10 | -16.34 | -27.88 | -18.08 | -30.94 | 77.70 | 85.03 | -23.82 | -51.09 | 7.22 | -- | 0.1799 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Surmodics Inc | 126.08m | -11.54m | 561.12m | 389.00 | -- | 4.74 | -- | 4.45 | -0.8145 | -0.8145 | 8.90 | 8.30 | 0.6922 | 2.20 | 6.03 | 324,108.00 | -6.34 | -3.99 | -7.22 | -4.66 | 73.81 | 80.25 | -9.15 | -6.26 | 3.22 | -3.03 | 0.1991 | -- | -4.91 | 4.73 | -651.43 | -- | -12.34 | -- |
| AxoGen Inc | 180.86m | -14.31m | 587.07m | 426.00 | -- | 5.90 | -- | 3.25 | -0.3302 | -0.3302 | 4.16 | 2.26 | 0.9356 | 1.65 | 7.55 | 424,544.60 | -7.40 | -13.92 | -8.49 | -15.84 | 76.13 | 79.74 | -7.91 | -20.28 | 2.47 | -1.50 | 0.3224 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Mesa Laboratories Inc | 228.38m | -245.65m | 592.51m | 736.00 | -- | 3.66 | -- | 2.59 | -45.57 | -45.57 | 42.13 | 29.79 | 0.4186 | 2.74 | 5.96 | 310,298.90 | -45.02 | -9.20 | -54.70 | -9.88 | 62.47 | 60.60 | -107.56 | -28.33 | 0.5106 | 1.35 | 0.5594 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
| Standard Biotools Inc | 155.90m | -170.60m | 595.61m | 534.00 | -- | 1.22 | -- | 3.82 | -0.7091 | -0.7091 | 0.5579 | 1.31 | 0.3054 | 2.48 | 6.01 | 291,951.30 | -24.41 | -28.17 | -29.37 | -33.60 | 48.57 | 51.58 | -79.91 | -74.85 | 3.41 | -- | 0.1014 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| Simulations Plus Inc | 70.01m | 9.95m | 628.50m | 243.00 | 63.99 | 3.44 | 40.24 | 8.98 | 0.4894 | 0.4894 | 3.45 | 9.10 | 0.3659 | -- | 5.55 | 288,119.30 | 5.20 | 6.10 | 5.55 | 6.45 | 61.63 | 74.01 | 14.22 | 18.97 | -- | -- | 0.00 | 45.64 | 17.52 | 15.56 | -0.0703 | 3.01 | 17.07 | 0.00 |
| Orthopediatrics Corp | 189.67m | -28.44m | 637.85m | 247.00 | -- | 1.72 | -- | 3.36 | -1.24 | -1.24 | 8.26 | 15.32 | 0.4116 | 0.4509 | 4.71 | 767,906.90 | -6.17 | -5.40 | -6.78 | -5.93 | 73.68 | 75.09 | -15.00 | -15.92 | 3.68 | -29.23 | 0.1638 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| Iradimed Corp | 71.31m | 18.63m | 674.61m | 148.00 | 36.46 | 8.08 | 34.68 | 9.46 | 1.46 | 1.46 | 5.59 | 6.59 | 0.7851 | 1.42 | 6.16 | 481,791.50 | 20.51 | 13.16 | 22.48 | 14.58 | 77.14 | 76.55 | 26.12 | 21.46 | 7.82 | 143.27 | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Varex Imaging Corp | 811.00m | -47.70m | 680.58m | 2.30k | -- | 1.28 | -- | 0.8392 | -1.16 | -1.16 | 19.77 | 13.02 | 0.6576 | 2.04 | 5.05 | 352,608.70 | -3.83 | -0.1231 | -4.54 | -0.146 | 31.68 | 31.59 | -5.82 | -0.1748 | 1.97 | 1.40 | 0.4502 | -- | -9.22 | 0.767 | -198.96 | -- | 6.32 | -- |
| Butterfly Network Inc | 76.22m | -98.51m | 690.32m | 225.00 | -- | 3.80 | -- | 9.06 | -0.4708 | -0.4708 | 0.3627 | 0.8537 | 0.2543 | 0.6416 | 4.45 | 338,755.60 | -32.87 | -- | -38.53 | -- | 29.60 | -- | -129.25 | -- | 2.95 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Orthofix Medical Inc | 784.25m | -119.03m | 722.63m | 1.63k | -- | 1.37 | -- | 0.9214 | -3.14 | -3.14 | 20.72 | 13.76 | 0.8844 | 1.17 | 6.56 | 479,956.60 | -13.42 | -8.88 | -16.31 | -10.96 | 68.05 | 72.37 | -15.18 | -9.28 | 1.11 | -3.12 | 0.2069 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Embecta Corp | 1.12bn | 69.70m | 797.44m | 2.20k | 11.45 | -- | 7.36 | 0.7127 | 1.21 | 1.21 | 19.36 | -13.24 | 0.8882 | 2.11 | 11.60 | 508,590.90 | 5.53 | -- | 7.91 | -- | 66.42 | -- | 6.23 | -- | 1.61 | 2.06 | 1.88 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Figs Inc | 548.65m | 10.84m | 800.40m | 354.00 | 79.99 | 1.98 | 48.33 | 1.46 | 0.059 | 0.059 | 3.08 | 2.38 | 1.11 | 1.33 | 65.26 | 1,549,845.00 | 2.20 | -- | 2.64 | -- | 67.67 | -- | 1.97 | -- | 3.28 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
Data as of Nov 25 2024. Currency figures normalised to Simulations Plus Inc's reporting currency: US Dollar USD
44.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2024 | 2.30m | 11.49% |
| Conestoga Capital Advisors LLCas of 30 Sep 2024 | 1.94m | 9.68% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 1.11m | 5.53% |
| Ranger Investment Management LPas of 30 Sep 2024 | 902.00k | 4.51% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 640.30k | 3.20% |
| Ophir Asset Management Pty Ltd.as of 30 Sep 2024 | 598.18k | 2.99% |
| Geode Capital Management LLCas of 30 Sep 2024 | 448.62k | 2.24% |
| Voya Investment Management Co. LLCas of 30 Sep 2024 | 376.74k | 1.88% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 355.11k | 1.78% |
| Threadneedle Asset Management Ltd.as of 30 Sep 2024 | 329.02k | 1.64% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
